German scientists have discovered a method of treatment that appreciably slows the progress of the fatal brain disease scrapie in mice.
Researchers from the universities of Munich and Bonn, together with colleagues at the Max Planck Institute in Martinsried, used an effect discovered by U.S. researchers Craig Mello and Andrew Fire, for which they were awarded this year's Nobel Prize for Medicine.
Scrapie is a variant of the cattle disease bovine spongiform encephalopathy, or mad cow disease, and the human equivalent Creutzfeldt-Jakob disease.
Scrapie, Creutzfeldt-Jakob and BSE are among the most unusual diseases known to medical research because the pathogens are apparently neither viruses nor bacteria, being simply protein molecules known as protein prions.
What is even more peculiar: the same prion proteins occur in healthy animals, the only difference being they have an unusual shape. When there is contact with their "diseased twins" they change their shape, also becoming "diseased.
The new, complex treatment, however, will require years of study before it can be applied to human medicine, the researchers said.
They detail their findings in the December issue of the Journal of Clinical Investigation.
Copyright 2006 by United Press International
Related stories:
New evidence on the robustness of metabolic networks
Biological systems are constantly evolving in ways that increase their fitness for survival amidst environmental fluctuations and internal errors. Now, in a study of cell metabolism, a Northwestern University research team has found new evidence that evolution has produced cell metabolisms that are especially well suited to handle potentially harmful changes like gene deletions and mutations.
Studies spot numerous undiscovered gene alterations in pancreatic and brain cancers
HHMI investigators have detected a multitude of broken, missing, and overactive genes in pancreatic and brain tumors, in the most detailed genetic survey yet of any human tumor. Some of these genetic changes were previously unknown and could provide new leads for improved diagnosis and therapy for these devastating cancers.
New 'trick' allows HIV to overcome a barrier to infection
Researchers have discovered a new 'trick' that allows HIV to overtake resting T cells that are normally highly resistant to HIV infection, according to a report in the September 5th issue of the journal
Cell. The binding of the virus to the surface of those cells sends a signal that breaks down the cells' internal skeleton, a structure that otherwise may present a significant barrier to infection.
Potential remedy for the 'mental fog' in cancer patients
Cancer patients have complained for years about the mental fog known as chemobrain. Now in animal studies at West Virginia University (WVU), researchers have discovered that injections of N-acetyl cysteine (NAC), an antioxidant, can prevent the memory loss that breast cancer chemotherapy drugs sometimes induce. The WVU researchers' study has just been published in the September issue of the Springer journal
Metabolic Brain Disease.
New nano device detects immune system cell signaling
Scientists have detected previously unnoticed chemical signals that individual cells in the immune system use to communicate with each other over short distances.
Gene is likely cause of stroke-inducing vascular malformations
UCSF scientists have discovered that a gene controlling whether blood vessels differentiate into arteries or veins during embryonic development is linked to a vascular disorder in the brain that causes stroke.
Surgical technique halts cell loss, Parkinson's researchers find
Deep brain stimulation, a surgical technique often viewed as a last resort for people with Parkinson's disease, halts the progression of dopamine-cell loss in animal models, according to preliminary research by scientists at the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital.
Got Gout? Duke Leads Study of New Treatment
(PhysOrg.com) -- A new drug designed to normalize levels of uric acid in the blood appears to be safe and tolerable and may help patients with the painful arthritic condition known as gout better cope with their disease, say researchers at Duke University Medical Center.